CM Management’s Coya Therapeutics COYA Stock Holding History

CM Management’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.34M	Buy	400,000 +25,000	+7%	+$116K	1.49%	28
2026 Q1	$1.48M	Buy	375,000 +25,000	+7%	+$117K	1.24%	28
2025 Q4	$2.03M	Buy	350,000 +50,000	+17%	+$304K	1.71%	19
2025 Q3	$1.71M	Buy	300,000 +100,000	+50%	+$608K	1.43%	25
2025 Q2	$1.15M	Hold	200,000	–	–	1.05%	35
2025 Q1	$1.29M	Buy	200,000 +40,000	+25%	+$253K	1.3%	33
2024 Q4	$917K	Buy	160,000 +15,941	+11%	+$109K	0.82%	43
2024 Q3	$929K	Buy	144,059 +44,059	+44%	+$278K	0.74%	48
2024 Q2	$606K	Hold	100,000	–	–	0.56%	49
2024 Q1	$992K	Hold	100,000	–	–	0.83%	44
2023 Q4	$741K	Hold	100,000	–	–	0.6%	47
2023 Q3	$384K	Buy	100,000 +40,000	+67%	+$159K	0.41%	51
2023 Q2	$244K	Buy	+60,000	New	+$278K	0.24%	68

Other funds holding COYA

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CM Management's COYA Position: Q2 2026 in Review

CM Management increased its Coya Therapeutics (COYA) stake by 6.7% in Q2 2026, buying an estimated $116K and bringing the position to 400,000 shares worth $2.34M. The position accounts for 1.49% of the portfolio, ranked #28.

CM Management first reported a position in COYA in Q2 2023 and has held it in 13 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

CM Management held 400,000 shares of Coya Therapeutics worth $2.34M as of Q2 2026.
CM Management bought 25,000 Coya Therapeutics shares in Q2 2026, an estimated $116K.
Coya Therapeutics made up 1.49% of CM Management's portfolio in Q2 2026, its #28 holding.
CM Management first reported a position in Coya Therapeutics in Q2 2023 and has held it in 13 quarters since.
54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.